Optimizing HPV Vaccination: Improving Communication Through Ethical Principles and Evidence-based Clinical Strategies

Overview

A clinician recommendation plays a critical role in getting parents to accept HPV vaccination for their child. This presentation was developed to support health care providers, nurses, and clinical staff at The Children’s Hospital of San Antonio Primary Care clinics. It covers the principles of medical ethics and how they apply to HPV vaccination, the importance of HPV vaccination for cancer prevention, organizational approaches to improve HPV vaccine delivery in the clinical setting, and effective strategies to communicate with parents about HPV vaccination.

Target Audience

This CME/CE activity is designed to meet the educational needs of Pediatricians, Registered Nurses, and Advanced Practice Registered Nurses serving adolescent patients in Texas clinics.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

Recognize how ethical principles apply to HPV vaccination and parent-provider communication about the HPV vaccine
Describe the importance of HPV vaccination for cancer prevention and the rationale for vaccinating all adolescents at ages 11 or 12
Apply effective strategies to improve communication with parents about HPV vaccination

Acknowledgement of Support

This CME/CE activity is supported by an educational grant from the Cancer Prevention and Research Institute of Texas (CPRIT) grant PP190041.

Course summary

Available credit:

1.00 AMA PRA Category 1 Credit™
1.00 ANCC
1.00 Ethics
1.00 Participation

Course opens:

09/01/2020

Course expires:

09/30/2022

Rating:

Method of Participation

This activity is in an online video module format and includes one didactic presentation.

To receive a certificate you should:

View the presentation in this enduring material.
Complete the posttest (you must answer 7 out of 10 questions correctly).
Complete and submit the CME/CE evaluation form.

The estimated time to complete this activity, including review of the materials, is 1.00 hour(s).

Hardware/software requirements: Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox, and Google Chrome.

If you have questions about the participation process, please e-mail the Division of Continuing Professional Development, cpd@bcm.edu or phone 713.798.8237.

Term of Approval

September 2020 through September 2022. Original release date: September 2020

Disclaimer

This CME/CE activity is designed for use by healthcare professionals for educational purposes only. Information and opinion offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDA-approved uses and information.

Baylor College of Medicine makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Links are provided to other Internet sites solely for the convenience of users. Once you link to another site, you are subject to the site's terms and conditions of use including copyright and licensing restrictions.

DRUG/DEVICE STATUS DISCLOSURE

Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with the applicable law.

Baylor College of Medicine requires that all contributors disclose an unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products, and provide adequate scientific and clinical justification for such use. Physicians are urged to fully review all the available data on products or procedures before using them to treat patients.

DISCLOSURE POLICY

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CME activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME’s validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

C, Mary Healy, M.D., M.P.H., Program Director, Presenter
Associate Professor of Medicine
Infectious Disease Section
Baylor College of Medicine
Houston, Texas

Disclosure:
Honorarium Recipient: National Foundation of Infectious Diseases, Infectious Disease Society of America, UpToDate

The following individual(s) has/have reported no financial or other relationships with commercial entities whose products/services may relate to the educational content of this activity:

Erica Frost, M.P.H., Planning Committee Member
Program Manager-Research
The University of Texas Health Science Center at Houston, School of Public Health
Houston, Texas